Literature DB >> 19818304

Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.

Kenneth Cusi1.   

Abstract

It is well established that the development of NAFLD and NASH are closely linked to an excess flow of free fatty acids (FFA) arising from dysfunctional/insulin resistant adipose tissue causing ectopic fat deposition in many organs. In the liver, when chronic lipid supply surpasses the metabolic ability to adapt it will induce hepatocellular damage as FFA are redirected into harmful pathways of non-oxidative metabolism with intracellular accumulation of toxic lipid-derived metabolites. Multiple mechanisms have been implicated including mitochondrial dysfunction, endoplasmic reticulum stress, and activation of multiple inflammatory pathways. Understanding the role of insulin resistance and lipotoxicity in NASH as part of a broader metabolic disorder is likely to assist practitioners in the successful management of these challenging patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818304     DOI: 10.1016/j.cld.2009.07.009

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  63 in total

1.  FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy.

Authors:  Shenglong Zhu; Yunzhou Wu; Xianlong Ye; Lei Ma; Jianying Qi; Dan Yu; Yuquan Wei; Guangxiao Lin; Guiping Ren; Deshan Li
Journal:  Mol Cell Biochem       Date:  2016-07-19       Impact factor: 3.396

2.  Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).

Authors:  Maria Stepanova; Nila Rafiq; Hala Makhlouf; Ritambhara Agrawal; Ishmeet Kaur; Zahra Younoszai; Arthur McCullough; Zachary Goodman; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2013-06-18       Impact factor: 3.199

3.  Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis.

Authors:  Renfan Xu; Anyu Tao; Shasha Zhang; Youbin Deng; Guangzhi Chen
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.

Authors:  Géraldine Gentric; Vanessa Maillet; Valérie Paradis; Dominique Couton; Antoine L'Hermitte; Ganna Panasyuk; Bernard Fromenty; Séverine Celton-Morizur; Chantal Desdouets
Journal:  J Clin Invest       Date:  2015-01-26       Impact factor: 14.808

Review 5.  Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Melinda Frye; Michael J Pagliassotti
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

6.  Glitazones for human nonalcoholic steatohepatitis.

Authors:  Raluca Pais; Ioana Moraru; Vlad Ratziu
Journal:  Therap Adv Gastroenterol       Date:  2011-09       Impact factor: 4.409

Review 7.  Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Authors:  Romina Lomonaco; Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

8.  Sodium acetate improves disrupted glucoregulation and hepatic triglyceride content in insulin-resistant female rats: involvement of adenosine deaminase and dipeptidyl peptidase-4 activities.

Authors:  Tolulope Eniola Omolekulo; Olugbenga Samuel Michael; Lawrence Aderemi Olatunji
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-02       Impact factor: 3.000

9.  The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver.

Authors:  Stella M Daniele; Silvana M Montenegro; María C Tarres; Juan C Picena; Stella M Martinez
Journal:  Diabetol Metab Syndr       Date:  2010-03-17       Impact factor: 3.320

10.  A simple index of lipid overaccumulation is a good marker of liver steatosis.

Authors:  Giorgio Bedogni; Henry S Kahn; Stefano Bellentani; Claudio Tiribelli
Journal:  BMC Gastroenterol       Date:  2010-08-25       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.